[
  {
    "ts": null,
    "headline": "Edwards Lifesciences (EW) Earnings Transcript",
    "summary": "Bernard Zovighian: Thank you, Mark and welcome everyone.  This strong Q3 results represent another quarter of double-digit sales growth.  Sales in the quarter grew 12.6% to $1.55 billion driven by our comprehensive portfolio across multiple therapeutic areas, aortic, pulmonic, mitral and tricuspid as well and -- as well as an established presence in countries around the world.",
    "url": "https://finnhub.io/api/news?id=ab44a931f08b2f847c742abc2f047bd4dbcbb5fb4fb512e29a6a8388c801c05b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764289176,
      "headline": "Edwards Lifesciences (EW) Earnings Transcript",
      "id": 137628511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Bernard Zovighian: Thank you, Mark and welcome everyone.  This strong Q3 results represent another quarter of double-digit sales growth.  Sales in the quarter grew 12.6% to $1.55 billion driven by our comprehensive portfolio across multiple therapeutic areas, aortic, pulmonic, mitral and tricuspid as well and -- as well as an established presence in countries around the world.",
      "url": "https://finnhub.io/api/news?id=ab44a931f08b2f847c742abc2f047bd4dbcbb5fb4fb512e29a6a8388c801c05b"
    }
  }
]